Data as of Nov 4, 2026.
FMED vs TNXT: Holdings Overlap & Returns
FMED and TNXT hold 10% of their weight in the same names.
askIQ about this page
askIQ about FMED and TNXT
Net assets: $52m on Sep 30, 2026 for Fidelity Disruptive Medicine ETF, and $19m on Nov 3, 2026 for T. Rowe Price Innovation Leaders ETF.
22% of FMED's weight is in S&P 500 companies and 78% is outside the index. Holdings as of Aug 31, 2026.
64% of TNXT's weight is in S&P 500 companies and 36% is outside the index. Holdings as of Jun 30, 2026.
Pair scorecard
TNXT costs 0.01 points a year less.
| Measure | FMED | TNXT |
|---|---|---|
| Return | ||
| Total return, 1 year | +27.4% | not published |
| Benchmark | ||
| What it tracks | Broad innovation and megatrends | Broad innovation and megatrends |
| Cost and size | ||
| Expense ratio | 0.50% | 0.49% |
| Net assets, FMED as of Sep 30, 2026 and TNXT as of Nov 3, 2026 | $52m | $19m |
| Holdings | ||
| Holdings in common | 10% | |
Risk and return
Feb 6, 2026 to Oct 30, 2026 · 38 weekly returnsFrom Feb 2026 to Oct 2026, FMED returned more: +25.7% to +15.6%. TNXT fell slightly less at its worst: −9.5% to −9.8%.
Full scorecard
3 measures, with how each is measured Open ↓
| Measure | FMED | TNXT | Edge | How it is measured |
|---|---|---|---|---|
| Return | ||||
| Total return | +25.7% | +15.6% | FMED | Price change plus distributions, reinvested. |
| Price return | +25.7% | +15.6% | FMED | Price change alone, distributions left out. |
| Risk | ||||
| Max drawdown | −9.8% | −9.5% | TNXT (slight) | Deepest fall from a high to the low after it. |
Computed by ETFIQ from Tiingo daily prices and ETFIQ's distribution records, 38 weekly returns. Cash rate: the 13-week Treasury bill.
What they share
By the books each fund has filed, FMED and TNXT hold 10% of their money in the same securities at the same weight. Holdings dated Jun 30, 2026 and Aug 31, 2026.
half
10% in common
Only in one fund ↓
Window by window
| Total return | ||
|---|---|---|
| Window | FMED | TNXT |
| 3 months | +14.9% | −0.2% |
| 6 months | +31.2% | +6.6% |
| 1 year | +27.4% | – |
| 3 years | +57.8% | – |
| Since launchNot the same days: FMED Jun 2023 · TNXT Jan 2026 | +31.7% | +13.4% |
– means no data for this window. Open this comparison in the app →
Side by side
As of Nov 4, 2026. Source: ETFIQ.
10% of the two portfolios are the same securities at the same weight.
No client brief for this pair: ETFIQ prints no one-year total return for TNXT.
FMED
By weight, 22% of FMED's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 33% of the fund across 72 positions, as filed for Aug 31, 2026. Over the year to Nov 4, 2026 the fund returned +27.4% with distributions reinvested.
TNXT
By weight, 64% of TNXT's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 52%. The top ten holdings are 32% of the fund across 272 positions, as filed for Jun 30, 2026. Since it first traded on Jan 29, 2026 the fund returned +13.4% with distributions reinvested.
Questions people ask
- Do FMED and TNXT hold the same stocks?
- By their latest filings, 10% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.
Links are sources, not endorsements. A comparison is not a recommendation.
How this is computed
Overlap adds up the smaller of the two weights for each security both funds hold.
Every number is an ETFIQ calculation with distributions reinvested.
Cite this pageCitation, APA and Markdown
ETFIQ, FMED against TNXT, data as of Nov 4, 2026. https://etfiq.com/compare/themes/fmed-vs-tnxt
ETFIQ. (Nov 4, 2026). FMED against TNXT. Retrieved from https://etfiq.com/compare/themes/fmed-vs-tnxt
[FMED against TNXT (ETFIQ, Nov 4, 2026)](https://etfiq.com/compare/themes/fmed-vs-tnxt)
Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.